CN102133380A - Medicament for treating cervical spondylosis - Google Patents

Medicament for treating cervical spondylosis Download PDF

Info

Publication number
CN102133380A
CN102133380A CN 201110084433 CN201110084433A CN102133380A CN 102133380 A CN102133380 A CN 102133380A CN 201110084433 CN201110084433 CN 201110084433 CN 201110084433 A CN201110084433 A CN 201110084433A CN 102133380 A CN102133380 A CN 102133380A
Authority
CN
China
Prior art keywords
parts
medicament
cervical spondylosis
pain
treating
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CN 201110084433
Other languages
Chinese (zh)
Other versions
CN102133380B (en
Inventor
李秋荣
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Haimen Zhi Zhou Industrial Design Co., Ltd.
Original Assignee
李秋荣
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 李秋荣 filed Critical 李秋荣
Priority to CN2011100844336A priority Critical patent/CN102133380B/en
Publication of CN102133380A publication Critical patent/CN102133380A/en
Application granted granted Critical
Publication of CN102133380B publication Critical patent/CN102133380B/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Landscapes

  • Medicines Containing Plant Substances (AREA)

Abstract

The invention belongs to the technical field of medicaments and particularly relates to a medicament for treating cervical spondylosis. The invention provides a medicament which has an obvious effect and small toxic and side effects and is used for treating cervical spondylosis. The medicament is used for treating numb, pain, limitation of activity and the like in limbs caused by cervical vertebra osteoproliferation and cervical spondylosis, and is prepared from the following raw material medicaments in part by weight: 15 parts of astragalus, 10 parts of liquoric root, 10 parts of bupleurum, 10 parts of ephedra, 10 parts of szechuan lovage rhizome, 5 parts of suberect spatholobus stem, 5 parts of safflower, 5 parts of bunge auriculate root and 5 parts of curcuma aromatica. The invention has the advantages that: the medicament has the effects of relaxing tendons and removing obstruction in channels and relieving spasm and pain, is used for treating the numb, pain and limitation of activity in limbs caused by the cervical vertebra osteoproliferation and the cervical spondylosis, and has an obvious effect; and the raw material medicaments in the medicament are traditional Chinese medicaments, and do not have toxic or side effect, so the medicament can be taken safely.

Description

A kind of medicine for the treatment of cervical spondylosis
Technical field
The invention belongs to medical technical field, be specifically related to a kind of medicine for the treatment of cervical spondylosis.
Background technology
Cervical spondylosis is the root of multiple disease, and along with modern society's rhythm of life is accelerated, working method changes, computer, air-conditioning extensive use, people suffer the wind-cold damp pathogen invasion and attack and bend the neck probability to increase considerably, and cause the cervical spondylosis sickness rate constantly to rise, and age of onset constantly shift to an earlier date.
Cervical spondylosis claims cervical spine syndrome again, is the general name that osteoarthritis of cervical spine, proliferative cervical spondylosis, cervical syndrome, cervical intervertebral disk are deviate from disease, is a kind of illness of changing into the basis with degeneration pathology.Mainly due to cervical vertebra strain for a long time, hyperosteogeny, or prolapse of intervertebral disc, ligament thicken, and causes cervical vertebra spinal cord, nerve root or vertebral artery pressurized, causes a series of handicapped clinical syndromes.Show as intervertebral disc degradation itself and insecondary a series of pathological change thereof, as vertebra joint unstability, loosening; Vertebral pulp is given prominence to or is deviate from; Bony spur forms; The spinal canal stenosis of ligament plumpness and secondary etc. stimulate or have oppressed the tissues such as nerve root, spinal cord, vertebral artery and cervical region sympathetic nerve of vicinity, and cause the syndrome of various sings and symptoms.
At cervical spondylosis, multiple therapy is arranged at present.Physiotherapy has the traction treatment that utilizes various machineries, massotherapy, thermotherapy, magnetic therapy etc., and effect is not ideal enough, and the medicine of treatment hyperosteogeny mostly is medicine for external use, generally can only relief of symptoms, though oral medicine is also arranged, toxicity is big, should not obey for a long time.So, pressing for determined curative effect, toxic and side effects is little, is suitable for the medicine of taking for a long time.
Summary of the invention
The invention provides the medicine of the treatment cervical spondylosis that a kind of effect is remarkable, toxic and side effects is little, be used for numb limbs and tense tendons, pain that hyperosteogeny of cervical vertebra, cervical spondylosis cause, limitation of activity etc.
The traditional Chinese medical science thinks how weak with age hyperosteogeny is, qi depression to blood stasis, and the damp and hot expectorant stasis of blood hinders in the passages through which vital energy circulates joint, due to QI and blood is not smooth, with nourshing blood and promoting blood circulation, the kidney tonifying circulation of qi promoting, dispelling wind and removing obstruction in the collateral, removing damp and stopping pain are the Therapeutic Principle.The present invention is based on pathogeny " all kinds of diseases and ailments all be born in expectorant; all kinds of diseases and ailments all be born in the stasis of blood ", " institute of heresy gather; its gas must empty ", " pain then obstructed " of the traditional Chinese medical science to cervical spondylosis, select that blood circulation promoting and blood stasis dispelling, nourishing and enriching blood, collateral dredging are active for use, expelling wind and cold, reduce phlegm and win wet, nourishing the liver and kidney, strong muscles and bones, the antiinflammatory bullate medicine of dispelling, with strengthening vital QI to eliminate pathogenic factors, strong positive bone strengthening, dissipating blood stasis antiinflammatory, improve blood circulation, suppress to eliminate edema, thereby reach the purpose of treatment cervical spondylosis.
The present invention treats the medicine of cervical spondylosis and gropes in a large number to sum up to draw through the inventor, is to be made by following bulk drugs: 15 parts of the Radixs Astragali, 10 parts in Radix Glycyrrhizae, 10 parts of Radix Bupleuri, 10 parts in Herba Ephedrae, 10 parts of Rhizoma Chuanxiongs, 5 parts of Caulis Spatholobis, 5 parts on Flos Carthami, 5 parts of Radix Cynanchi Auriculatis, 5 parts of Radix Curcumaes.
The Radix Astragali: invigorating QI to consolidate the body surface resistance, diuresis poison holding.
Radix Glycyrrhizae: heat-clearing and toxic substances removing, expelling phlegm for arresting cough.
Radix Bupleuri: reducing fever by reconciliation, dispersing the stagnated live-QI to relieve the stagnation of QI, elevate a turnable ladder yang-energy.
Herba Ephedrae: diaphoresis, relieving asthma, diuretic.
Rhizoma Chuanxiong: blood-activating and qi-promoting, activating QI to alleviate the depression, wind-expelling pain-stopping.
Caulis Spatholobi: enrich blood, invigorate blood circulation, collateral dredging.Be used for blood deficiency and yellow complexion, paralysis and numbness, rheumatic arthralgia.
Flos Carthami: be used for promoting blood circulation to restore menstrual flow, the blood stasis removing pain relieving.
Radix Cynanchi Auriculati: strengthening by means of tonics, nourish blood and enrich blood, crow palpus hair color, convergence vital essence, promoting tissue regeneration and ulcer healing, loosening bowel to relieve constipation.
Radix Curcumae: regulating qi to disperse stagnation, heart fire-clearing upset-relieving, promoting the function of the gallbladder to alleviate jaundice.
Beneficial effect of the present invention: medicine of the present invention, channels sootheing and network vessel quickening is arranged, the effect of relieving spasm to stop pain is used for numb limbs and tense tendons, pain and limitation of activity that hyperosteogeny of cervical vertebra, cervical spondylosis cause, and effect is remarkable; And raw materials used medicine is Chinese medicine, and almost non-toxic side effect can relievedly eat.
The specific embodiment:
A kind of medicine for the treatment of cervical spondylosis is prepared from by following crude drug:
15 parts of the Radixs Astragali, 10 parts in Radix Glycyrrhizae, 10 parts of Radix Bupleuri, 10 parts in Herba Ephedrae, 10 parts of Rhizoma Chuanxiongs, 5 parts of Caulis Spatholobis, 5 parts on Flos Carthami, 5 parts of Radix Cynanchi Auriculatis, 5 parts of Radix Curcumaes.
Preparation method: the above-mentioned raw materials medicine is weighed up by weight, and the water of putting into 10 times of weight boiled 2-4 hour, filtered out medicinal residues, and concentrated filtrate becomes dry extract, pulverized, and was pressed into tablet or made capsule.
Clinical experiment
1, physical data
Among the 743 routine patients, male's 496 examples, women's 247 examples, men and women's ratio 2:1, sick time weak point person three months, elder reach 5~6 years.
, diagnostic criteria
All patients all make a definite diagnosis through X-ray photograph or CT examination, and make a definite diagnosis in conjunction with patient's symptom analysis.
, clinical symptoms
In 743 routine patients, dizzy 188 examples account for 25.30%; Restriction of neck motion shoulder pain 234 examples account for 31.50%; Lower limb moving difficulty 13 examples account for 1.75%; Dizzy vomiting 17 examples account for 2.29%, and soft unable 78 examples of body account for 10.50%, and numbness of lower limbs 213 examples account for 28.66%.
, treatment rule and medication
According to the differentiation of tcm rule,,, adopt three months one courses of treatment of Drug therapy of pharmaceutical composition of the present invention with the method for channels sootheing and network vessel quickening, relieving spasm to stop pain in conjunction with the modern medicine scientific methods.
, criterion of therapeutical effect
Criterion of therapeutical effect is divided 4 grades: healing, produce effects, effective, invalid.
Effective percentage=(curing number+produce effects number+significant figure)/patient example number * 100%.
, therapeutic outcome:See the following form 1.
Table 1 Drug therapy cervical spondylosis of the present invention effect table
7, conclusion
Use checking through 743 routine patients, the total effective rate of treatment cervical spondylosis is 94.89%, illustrates that medicine of the present invention has significant curative effect to the treatment cervical spondylosis.

Claims (1)

1. medicine for the treatment of cervical spondylosis is characterized in that being made by following bulk drugs:
15 parts of the Radixs Astragali, 10 parts in Radix Glycyrrhizae, 10 parts of Radix Bupleuri, 10 parts in Herba Ephedrae, 10 parts of Rhizoma Chuanxiongs,
5 parts of Caulis Spatholobis, 5 parts on Flos Carthami, 5 parts of Radix Cynanchi Auriculatis, 5 parts of Radix Curcumaes.
CN2011100844336A 2011-04-06 2011-04-06 Medicament for treating cervical spondylosis Active CN102133380B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN2011100844336A CN102133380B (en) 2011-04-06 2011-04-06 Medicament for treating cervical spondylosis

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN2011100844336A CN102133380B (en) 2011-04-06 2011-04-06 Medicament for treating cervical spondylosis

Publications (2)

Publication Number Publication Date
CN102133380A true CN102133380A (en) 2011-07-27
CN102133380B CN102133380B (en) 2012-03-28

Family

ID=44293393

Family Applications (1)

Application Number Title Priority Date Filing Date
CN2011100844336A Active CN102133380B (en) 2011-04-06 2011-04-06 Medicament for treating cervical spondylosis

Country Status (1)

Country Link
CN (1) CN102133380B (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105797107A (en) * 2016-04-19 2016-07-27 劳炳凤 Medicine for treating cervical spondylosis
CN106983783A (en) * 2016-01-18 2017-07-28 北京亚东生物制药有限公司 It is a kind of for Chinese medicine composition of cervical spondylopathy and preparation method thereof

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101721664A (en) * 2008-11-04 2010-06-09 王生 Traditional Chinese medicine for treating apoplectic hemiplegia and general paralysis

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101721664A (en) * 2008-11-04 2010-06-09 王生 Traditional Chinese medicine for treating apoplectic hemiplegia and general paralysis

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
> 20101130 苏国义等 神经根型颈椎病的古代文献认识 60-62 1 第18卷, 第11期 2 *

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN106983783A (en) * 2016-01-18 2017-07-28 北京亚东生物制药有限公司 It is a kind of for Chinese medicine composition of cervical spondylopathy and preparation method thereof
CN105797107A (en) * 2016-04-19 2016-07-27 劳炳凤 Medicine for treating cervical spondylosis

Also Published As

Publication number Publication date
CN102133380B (en) 2012-03-28

Similar Documents

Publication Publication Date Title
CN100423761C (en) Chinese medicinal preparation for treating fracture, traumatic injury
CN1118285C (en) Shubi plaster for treating arthralgia due to wind-cold-dampness
CN102872442A (en) Traditional Chinese medicine capsule for treating scapulohumeral periarthritis
CN104225508A (en) Traditional Chinese medicine composition for cervical spondylosis treatment and preparation method thereof
CN102133380B (en) Medicament for treating cervical spondylosis
CN101721651B (en) Traditional Chinese medicine capsule for treating scapulohumeral periarthritis
CN101293041B (en) Externally used medicament for treating protrusion of lumbar vertebral disc, spinal canal stenosis
CN1391943A (en) Chinese medicine paste for curing osteoarthropathy and preparing method
CN1772245A (en) Snake medicinal wine for health care massage and its application
CN105853969A (en) Traditional Chinese medicine composition for treating lumbar disc herniation and lumbar spinal stenosis and preparation method thereof
CN106138436A (en) A kind of Chinese medicine treating prolapse of lumbar intervertebral disc and hyperosteogeny and preparation method thereof
CN102125625B (en) Traditional Chinese medicine for treating ankylosing spondylitis
CN101700395B (en) Ointment for curing hyperosteogeny
CN101085303A (en) Oral administration traditional Chinese medicine composition for treating hyperplasia of mammary glands
CN103520429A (en) Traditional Chinese medicinal preparation used for treating rheumatic loin and leg pains
CN1241580C (en) Medicinal composition for treating hypersteogeny
CN103157072B (en) Chinese medicinal composition for treating cervical spondylosis
CN102327591B (en) Phlegm-eliminating pill
CN102614313A (en) Externally applied Chinese medicine spray for curing scapulohumeral periarthritis
CN103223012B (en) External traditional Chinese medicine composition for treating sudden sprain in lumbar region and acute chest pain and preparation method thereof
CN100406035C (en) Chinese medicine preparation for treating protrasion of lumbar intervertebral disc
CN101954043A (en) Medicament for treating hyperosteogeny and preparation method thereof
CN106420999A (en) Blood-activating decoction for treating joint degenerative changes
CN101040980A (en) Chinese traditional medicine compound for treating protrusion of lumbar intervertebral disc for external application
CN104740431A (en) Drug for treating cervical and lumbar diseases

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
ASS Succession or assignment of patent right

Owner name: LIU ZHAOJUN

Free format text: FORMER OWNER: LI QIURONG

Effective date: 20120117

C41 Transfer of patent application or patent right or utility model
C53 Correction of patent for invention or patent application
CB03 Change of inventor or designer information

Inventor after: Liu Chaojun

Inventor before: Li Qiurong

COR Change of bibliographic data

Free format text: CORRECT: ADDRESS; FROM: 250101 JINAN, SHANDONG PROVINCE TO: 272051 JINING, SHANDONG PROVINCE

Free format text: CORRECT: INVENTOR; FROM: LI QIURONG TO: LIU ZHAOJUN

TA01 Transfer of patent application right

Effective date of registration: 20120117

Address after: 272051 Shandong Province in Rencheng District of Jining City Li Ying Zhen Ji Dai Road No. 1 Jining city mental hospital

Applicant after: Liu Chaojun

Address before: Xindian garden Licheng District 250101 in Shandong province Ji'nan City No. 18 building 3 unit 702 room

Applicant before: Li Qiurong

C14 Grant of patent or utility model
GR01 Patent grant
ASS Succession or assignment of patent right

Owner name: JIANGSU HANCHEN PHARMACEUTICAL CO., LTD.

Free format text: FORMER OWNER: LIU CHAOJUN

Effective date: 20130701

C41 Transfer of patent application or patent right or utility model
COR Change of bibliographic data

Free format text: CORRECT: ADDRESS; FROM: 272051 JINING, SHANDONG PROVINCE TO: 226132 NANTONG, JIANGSU PROVINCE

TR01 Transfer of patent right

Effective date of registration: 20130701

Address after: 226132, three Bridge Road, Yue Yue Industrial Zone, Haimen, Jiangsu, Nantong 188, China

Patentee after: Jiangsu Hanchen Pharmaceutical Co., Ltd.

Address before: 272051 Shandong Province in Rencheng District of Jining City Li Ying Zhen Ji Dai Road No. 1 Jining city mental hospital

Patentee before: Liu Chaojun

ASS Succession or assignment of patent right

Owner name: NANTONG YUEYUE INDUSTRY CO., LTD.

Free format text: FORMER OWNER: JIANGSU HANCHEN PHARMACEUTICAL CO., LTD.

Effective date: 20150702

C41 Transfer of patent application or patent right or utility model
TR01 Transfer of patent right

Effective date of registration: 20150702

Address after: 226131 Jiangsu city of Nantong Province Haimen Yuelai town Fuxing Road, building 12, the town government compound

Patentee after: Nantong Yue Yue Industrial Co., Ltd.

Address before: 226132, three Bridge Road, Yue Yue Industrial Zone, Haimen, Jiangsu, Nantong 188, China

Patentee before: Jiangsu Hanchen Pharmaceutical Co., Ltd.

TR01 Transfer of patent right
TR01 Transfer of patent right

Effective date of registration: 20181221

Address after: 226100 Fuxing Road, Yuet Lai Town, Haimen, Nantong, Jiangsu, 18

Patentee after: Haimen Zhi Zhou Industrial Design Co., Ltd.

Address before: 226131 Government Courtyard, Building 12, Fuxing Road, Yuelai Town, Haimen City, Nantong City, Jiangsu Province

Patentee before: Nantong Yue Yue Industrial Co., Ltd.